NCT00004905View on ClinicalTrials.gov

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 1999

Study Completion Date

September 30, 2004

Conditions
Leukemia
Interventions
BIOLOGICAL

filgrastim

BIOLOGICAL

recombinant interferon alfa

DRUG

cyclophosphamide

DRUG

cytarabine

DRUG

etoposide

DRUG

idarubicin

PROCEDURE

peripheral blood stem cell transplantation

RADIATION

radiation therapy

Trial Locations (3)

60153

Loyola University Medical Center, Maywood

60611

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

60637

University of Chicago Cancer Research Center, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Loyola University

OTHER

NCT00004905 - Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia | Biotech Hunter | Biotech Hunter